Asthma is a chronic inflammatory airways disease, estimated to affect 300 million people
worldwide. Asthma management plans focus on optimisation of asthma pharmacotherapy …

Purpose Definitions and measures of asthma control used in clinical trials and in clinical
practice vary considerably. There is also misalignment between patients and healthcare …

Asthma management guidelines aim to improve the implementation of current knowledge
into daily clinical practice by establishing a consensus of scientific practices for the …

Treatable Traits personalises the management of airway diseases. 1, 2 This model of care
packages assessment of measurable, modifiable, and clinically relevant phenotypes, and …

Mild and moderate asthma cover a wide range of asthma presentations, phenotypes and
symptom burden, and account for the majority of people with asthma worldwide. Mild asthma …

Background While we have international guidelines and various national guidelines for
asthma diagnosis and management, asthma remains poorly controlled in many children and …

In recent decades, the concept of severe asthma has evolved from an umbrella term
encompassing patients with high-intensity treatment needs to a clinical syndrome with …

BACKGROUND: Current asthma guidelines recommend assessing the level of a patient's
asthma control. Consequently, there is increasing use of asthma control as an outcome …

Asthma is a heterogeneous and complex disease, and a description of asthma phenotypes
based on extrapulmonary treatable traits has not been previously reported. The objective of …

Background and objective Asthma and chronic obstructive pulmonary disease (COPD) are
two prevalent and complex diseases that require personalized management. Although a …